cancer

ooking to make the journey easier for patients of prostate cancer is Prostmate, a platform developed by Australian Prostate Cancer Research (APCR) and collaborators including Cancer Council Australia, St George Hospital, and Edith Cowan University.

Sydney healthtech startup CancerAid has announced the close of a $1.25 million Series B round, bringing the total valuation of the startup to $4.25 million. The app was created to help organise a patient’s cancer journey, helping sufferers to self manage their treatment and expectations.

Sydney healthtech startup CancerAid has launched in the Apple Store and has also signed 17 new customers, including its first international customer in Hong Kong. CancerAid is one of the world’s first apps to bring personalised cancer care to smartphones and is set to revolutionise patient care on a global scale. The startup is now in the process of raising $1.25 million in Seed funding.

Sydney startup Caring Canary offers handmade care packages for people suffering with cancer and going through the tough journey of chemotherapy. Founder of Caring Canary, Georgie Harley says this is the first of its kind in Australia and fills the gap in the market for convenient, meaningful and premium gifts.

After receiving a $1 million grant through the Federal Government’s Accelerating Commercialisation program earlier this year, biotech company Clarity Pharmaceuticals has announced it has raised a further $2 million in funding to help further develop its technology.

Whether you’re in for a broken arm or surgery, being in hospital is often scary. For people with cancer – and their families – the endless parade of doctors and treatments can be downright terrifying. There are countless, often time-sensitive decisions to be made and wading through all the medical terminology to understand all the options is difficult.

European non-for-profit organisation Medical Cannabis Bike Tour (MCBT) is launching a crowdfunding campaign on Walacea to finance an independent trial that investigates the effectiveness of cannabinoids (the active compounds in cannabis, CBD and THC) as a treatment for patients diagnosed with brain tumours.